Open access
Open access
Powered by Google Translator Translator

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.

25 Nov, 2021 | 10:23h | UTC

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey – The Lancet Oncology

Commentaries:

Access to and affordability of cancer medicines: time to focus on the last mile – The Lancet Oncology

Choosing Wisely, Researchers Look at Access to Essential Cancer Drugs on a Global Scale – The ASCO Post

Related: WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists.

 


Stay Updated in Your Specialty

No spam, just news.